MedTrace Logo

RCT of Uniport VATS for Lung Cancer

NCT04212481 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-11-16

No results posted yet for this study

Summary

Video-assisted thoracoscopic surgery (VATS) has been widely used for non-small cell lung cancer (NSCLC) for nearly two decades. Usually, it was applied through three ports with at least one drainage after surgery, which often lead to acute chest pain. Therefore, fewer, smaller ports, and wider intercostal space for surgery has been required.

Uniport VATS became a feasible option with the development of surgical techniques and instruments, with potentially less postoperative pain and shorter hospital stays. However, there may be some complications, or with a longer time of operation, even more difficult in lymph nodes resection during learning curve.

In our study, a Randomized Controlled Trial was designed to study the operation time, perioperative blood loss, conversion rate, duration of postoperative drainage, length of hospital stay, visual analogue score of postoperative pain, complications, and survival.

Conditions

  • Single-port Video-assisted Thoracoscopic Surgery

Interventions

PROCEDURE

uniport video-assisted thoracoscopic surgery

video-assisted thoracoscopic surgery for NSCLC using single port or two ports or three ports

PROCEDURE

two ports video-assisted thoracoscopic surgery

video-assisted thoracoscopic surgery for NSCLC using two ports

PROCEDURE

three ports video-assisted thoracoscopic surgery

video-assisted thoracoscopic surgery for NSCLC using three ports

Sponsors & Collaborators

  • The Second Hospital of Shandong University

    lead OTHER

Principal Investigators

  • Xiaogang Zhao, Doctor · The Second Hospital of Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-25
Primary Completion
2022-12-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04212481 on ClinicalTrials.gov